FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/02/104410 [Registered on: 20/02/2026] Trial Registered Prospectively
Last Modified On: 20/02/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Biological 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A comparative study to assess efficacy of platelet rich plasma with silver sulphadiazine versus silver sulphadiazine dressing in partial thickness burns 
Scientific Title of Study   A Randomised comparative study to assess efficacy of platelet rich plasma with silver sulphadiazine versus silver sulphadiazine dressing in partial thickness burns 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Anoosha Tresa Pius  
Designation  plastic Surgery Resident  
Affiliation  bangalore medical college  
Address  Fort, K.R. Road, Kalasipalyam, Bengaluru, Karnataka - 560002.

Bangalore
KARNATAKA
560002
India 
Phone  9645630588  
Fax    
Email  anushatresa43@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Ramesha K T  
Designation  Head of the Unit  
Affiliation  bangalore medical college  
Address  Plastic surgery department , 2 nd floor , PMSSY BUILDING , VICTORIA HOSPITAL , K R FORT, NEAR CITY MARKET , kalasipalyam

Bangalore
KARNATAKA
560002
India 
Phone  9645630588  
Fax    
Email  rameshktr@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Dr Anoosha Tresa Pius  
Designation  plastic Surgery Resident  
Affiliation  bangalore medical college  
Address  Plastic surgery department , 2 nd floor , PMSSY BUILDING , VICTORIA Hospital , K. R . FORT , near city market , KALASIPALAYAM,

Bangalore
KARNATAKA
560002
India 
Phone  9645630588  
Fax    
Email  anushatresa43@gmail.com  
 
Source of Monetary or Material Support  
nil 
 
Primary Sponsor  
Name  Bangalore medical college  
Address  Plastic surgery department , 2nd floor, PMSSY , VICTORIA HOSPITAL, Bangalore medical college,K.R. Road, Fort, Bengaluru - 560002. Landmark: Near City Market. 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Anoosha Tresa Pius   Bangalore Medical College   plastic surgery department , 2 nd floor PMSSY BUILDING ,Victoria Hospital, K.R. Fort, near city market , Kalasipalyam Bengaluru - 560002, Karnataka, India
Bangalore
KARNATAKA 
9645630588

anushatresa43@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Ethics Committee of BMCRI  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: T311||Burns involving 10-19% of body surface,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  AUTOLOGOUS Platelet rich plasma with silver sulphadiazine   Drop by drop, 7-8 CC of autologous PRP is gently poured onto the target area once in two days and allowed to dry for 15 minutes. PRP was used for 5 dressings ,every 2 days. After 15 minutes silver sulphadiazine is applied over wound in test group .  
Comparator Agent  Silver sulphadiazine   Only Silver sulphadiazine is applied on. the wound (Standard treatment for burns ). Regular dressing with it are done .  
 
Inclusion Criteria  
Age From  2.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1)Subjects with a deep partial-thickness burn injury covering 1- 20 % TBSA
2) Patient willing to give informed consent
3) Both sexes with an age of 2-60 years.
4)Subjects who were younger than the legal consenting age must have a legally authorized representative.
5) isolated burn area (not involving head and/or face) 
 
ExclusionCriteria 
Details  1)Subjects with inhalational injury or subjects being on a ventilator.
2)Treatment of the burn with an active agent before study entry.
3)Clinically infected burn
4)Diagnosed underlying disease(s) (e.g., HIV/AIDS, cancer, and severe anemia)
Judged by the investigator to be a potential interference in the treatment.
5) Use of immunosuppressive agents, radiation, or chemotherapy within the past 30d.
6) Subjects with physical and/or mental conditions who are not expected to comply with the investigation.
7) Pregnancy
8)Patient with haematological or coagulation disorders
9)Patients with any chronic skin disease
10) Electric or chemical burns
 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Healing rate
(epithelisation rate)
Scar Score(Vancouver Scar Score)
Pain Score
Time until skin graft
Ease of removal of the dressing



 
dressing is done for 5 days , every alternate day , patients are studied and followed for 21 days - day 0, day 2, day 4, day 6, day 8, day 14 and day 21  
 
Secondary Outcome  
Outcome  TimePoints 
nil  nil 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   04/03/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

This study is a randomised comparative trial evaluating the efficacy of platelet rich plasma combined along with  with silver sulphadiazine versus silver sulphadiazine alone in partial thickness burns. Silver sulphadiazine is the standard treatment but is associated with delayed healing pain and frequent dressing changes. Platelet rich plasma is an autologous blood product rich in growth factors that enhances angiogenesis epithelialization and tissue regeneration. Forty patients will be randomly assigned to two groups receiving either silver sulphadiazine alone or silver sulphadiazine with platelet rich plasma. Outcomes assessed include time to healing pain score scar score and need for skin grafting, easy pf change of dressing 

 
Close